Chase Coleman's HNGE Position Overview
Chase Coleman (via Tiger Global Management LLC) currently holds 1.81 M shares of Hinge Health, Inc. (HNGE) worth $83.88 M, representing 0.28% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 3 quarters.
Based on 13F filings, Chase Coleman has maintained this position in HNGE for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 1.25 M shares.
Analysis based on 13F filings available since 2013 Q2
Chase Coleman's Hinge Health (HNGE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Hinge Health (HNGE) Trades by Chase Coleman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +1.25 M | Add 227.12% | 1.81 M | $46.45 |
| Q2 2025 | +552,008 | New Buy | 552,008 | $51.75 |
Chase Coleman's Hinge Health Investment FAQs
Chase Coleman first purchased Hinge Health, Inc. (HNGE) in Q2 2025, acquiring 552,008 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chase Coleman has held Hinge Health, Inc. (HNGE) for 3 quarters since Q2 2025.
Chase Coleman's largest addition to Hinge Health, Inc. (HNGE) was in Q4 2025, adding 1,805,751 shares worth $83.88 M.
According to the latest 13F filing for Q4 2025, Chase Coleman's firm, Tiger Global Management LLC, owns 1,805,751 shares of Hinge Health, Inc. (HNGE), valued at approximately $83.88 M.
As of the Q4 2025 filing, Hinge Health, Inc. (HNGE) represents approximately 0.28% of Chase Coleman's publicly disclosed stock portfolio, making it one of their key holdings.
Chase Coleman's peak holding in Hinge Health, Inc. (HNGE) was 1,805,751 shares, as reported at the end of Q4 2025.